American Society of Head and Neck Radiology Report issue

Foundation

Organization Overview

First Clinical Trial
2012
NCT02080312
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

gadopenteate dimeglumine (magnevist) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1